がん研究のアーカイブ

  • ISSN: 2254-6081
  • ジャーナル h-index: 13
  • 雑誌引用スコア: 3.58
  • ジャーナルのインパクトファクター: 3.12
インデックス付き
  • 中国国家知識基盤 (CNKI)
  • サイテファクター
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • Google スカラー
  • 秘密検索エンジン研究所
このページをシェアする

抽象的な

Frankincense (Boswellia Species): The Novel Phytotherapy for Drug Targeting in Cancer

Rafie Hamidpour, Soheila Hamidpour, Mohsen Hamidpour and Roxanna Hamidpour

It seems that frankincense might have a potential ability to be used as an alternative natural medicine not only for cancer, chronic and inflammatory diseases but also for the patients with brain and memory disorders. Frankincense, the resinous extract from the trees of the genus Boswellia, has been used for centuries in ceremonial, cosmetic, cultural and as a traditional medicine to treat a variety of ailments especially cancer, inflammatory diseases including asthma, arthritis, cerebral edema, chronic pain syndrome, chronic bowel diseases, and some other illnesses. Boswellic acids are the active compounds of frankincense and AKBA (3-O-acetyl-11-keto-β-boswellic acid) is the most important and effective acid among them. Some studies have shown that the use of frankincense can also improve the learning and enhance the memory in animals and human.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません